A gene borrowed from the naked mole rat, an animal famous for extraordinary longevity and disease resistance, helped mice live a little longer and stay healthier, pointing to a surprising biological ...

TUCSON, Ariz. — Investigators looking to track down Nancy Guthrie’s suspected kidnappers are turning to a relatively new technology that has been attributed to solving some of the most prolific ...

ST. PETERSBURG, Fla. - Investigative genetic genealogy, which is a relatively new forensic tool, is now being considered in the search for answers in the Nancy Guthrie case. Big picture view ...

Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer Jennifer Doudna wants to build an entire ecosystem to bring these treatments ...

Antibiotic resistance (AR) has steadily accelerated in recent years to become a global health crisis. As deadly bacteria evolve new ways to elude drug treatments for a variety of illnesses, a growing ...

Eli Lilly and Company (NYSE:LLY) is included among the 12 Best Stocks to Buy for the Long Term. According to a report by Reuters, Eli Lilly and Company (NYSE:LLY) has signed an agreement worth up to ...

Scientists at The University of Texas at Austin have developed a revolutionary gene-editing method using bacterial retrons that can correct multiple disease-causing mutations at once. Unlike ...

Deepwater's Gene Munster joins 'Fast Money' to talk Intel quarterly results. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your ...

The Monroe County Sheriff’s Office and the Florida Department of Law Enforcement have identified two sets of human remains from separate unresolved cases — including a Hurricane Irma victim. The ...

Deepwater's Gene Munster joins 'Fast Money' to talk Intel quarterly results. People in Denmark 'stunned' by Trump's Greenland comments, former ambassador says Texas leads the nation in supplying new ...

ROCHESTER — Vyriad, a growing Rochester firm, recently raised an additional $25 million in funding to fuel its “race” to bring a new technology to market that accurately targets cancer within a ...